• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.45% Nasdaq Down1.03%

    Alexza Pharmaceuticals Inc. (ALXA)

    -NGM
    2.12 Down 0.10(4.41%) Jan 30, 3:59PM EST
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Net Income (13,328) (5,962) (10,735) (5,692)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation1,499  1,505  1,242  1,131  
    Adjustments To Net Income1,935  (7,056)1,968  (3,228)
    Changes In Accounts Receivables10  (740)(149)(104)
    Changes In Liabilities659  (1,116)(2,409)(1,724)
    Changes In Inventories(440)463  (990)(1,386)
    Changes In Other Operating Activities(126)(549)(77)342  
    Total Cash Flow From Operating Activities (9,791) (13,455) (11,150) (10,661)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(81)(2,287)(174)(296)
    Investments9,764  (33,130)8,575  65  
    Other Cash flows from Investing Activities -   -   -   -  
    Total Cash Flows From Investing Activities 9,683   (35,417) 8,401   (231)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -   -  
    Sale Purchase of Stock16  187  11  137  
    Net Borrowings1,201  6,135  38,750  (6,059)
    Other Cash Flows from Financing Activities -  (1)(250)10,313  
    Total Cash Flows From Financing Activities 1,217   6,321   38,511   4,391  
    Effect Of Exchange Rate Changes -   -   -   -  
    Change In Cash and Cash Equivalents 1,109   (42,551) 35,762   (6,501)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.